3 results
Approved WMOCompleted
To assess the impact of treatment with Lanreotide versus current standard of treatment on output reduction in patients with high output enterocutaneous fistula or high-output stoma.
Approved WMOCompleted
Primary objective:Part 1: To determine the safety, tolerability, and RP2D of a daily dosing schedule (induction) of GSK3745417 Part 2: To evaluate clinical efficacy following the daily dosing *induction* period of GSK3745417 in participants with…
Approved WMOCompleted
Primary Objective: to investigate if INPW will reduce wound complications such as wound dehiscence, wound infection (SSI), seroma leak and wound necrosis after arterial vascular surgery.Secondary Objective(s): to investigate if INPWT will prevent…